{
  "Cluster": "Neuroendocrine_II_P10",
  "CandidateSubtype": "embryonal",
  "TopGenes": [
    "MYH7B",
    "MATN3",
    "APCDD1",
    "CHGB",
    "ROBO1",
    "NKD1",
    "NRP2",
    "BMP4",
    "GNAS",
    "PLAT",
    "TMX4",
    "ZNRF3",
    "PTN",
    "ITGA8",
    "TGFB2",
    "CTSH",
    "SERPINI1",
    "BGN",
    "ZNF503",
    "LAMC1"
  ],
  "ProliferationScore": "0.080 (low)",
  "StemnessScore": "0.883 (high)",
  "ImmuneScore": "0.244 (low)",
  "PrognosticScore": "0.000 (low)",
  "SupportingEvidence": [
    "Neuroendocrine markers (CHGB, SERPINI1) and neuronal/axon guidance genes (ROBO1, NRP2, PTN) indicate immature/neuroendocrine-like phenotype consistent with embryonal regions.",
    "Wnt/\u03b2-catenin pathway regulators/targets (NKD1, APCDD1, ZNRF3) are characteristic of embryonal hepatoblastoma.",
    "Developmental signaling factors (BMP4, TGFB2) align with a less differentiated embryonal state.",
    "ECM/mesenchymal remodeling genes (LAMC1, ITGA8, BGN, MATN3) are enriched in embryonal/undifferentiated compartments."
  ],
  "SuggestedExperiments": [
    "IHC/IF for neuroendocrine markers (CHGA/CHGB, SYP, INSM1).",
    "IHC for \u03b2-catenin (nuclear) and sequencing of CTNNB1/APC to assess Wnt activation.",
    "IHC/ISH for subtype markers: fetal (ALB, HNF4A, GLUL) vs embryonal (AFP, DLK1).",
    "Ki-67 staining to quantify proliferation.",
    "Assess BMP/TGF-\u03b2 activity (pSMAD1/5/8 and pSMAD2/3).",
    "Correlate with histopathology to confirm embryonal morphology and exclude macrotrabecular pattern."
  ]
}